Prediction and assessment of response to neo‐adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists
Author:
Affiliation:
1. Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Florida USA
Publisher
Hindawi Limited
Subject
Oncology,Surgery,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.14274
Reference20 articles.
1. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
2. Preoperative/neoadjuvant medical therapy for early breast cancer
3. International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations
4. Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
5. Preoperative chemotherapy for women with operable breast cancer;Mieog J;Cochrane Database Syst Rev,2007
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients;World Journal of Surgical Oncology;2022-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3